Medication for opioid use disorder among adolescents entering specialty treatment for opioid use disorder and trends in the US, 2017–2022
Jesse Boggis(Dartmouth Institute for Health Policy and Clinical Practice), Erika L. Moen(Dartmouth College), Kenneth A. Feder(Johns Hopkins University), Wesley J. Marrero(Dartmouth College), Lisa A. Marsch(Dartmouth College)
Cited by 1
Related Papers
Bisphenol A exposure leads to specific microRNA alterations in placental cells
|Reproductive Toxicology|2010|266
Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits
|Genetics|2013|143
Prevalence of Children With Medical Complexity and Associations With Health Care Utilization and In-Hospital Mortality
|Archives of Pediatrics and Adolescent Medicine|2022|119
Analyzing Clustered Data: Why and How to Account for Multiple Observations Nested within a Study Participant?
|PLoS ONE|2016|84
New themes in the biological functions of 5‐methylcytosine and 5‐hydroxymethylcytosine
|Immunological Reviews|2014|68